Mylan launches Gilead Sciences’ Sovaldi tablets in India
Sovaldi is indicated for the treatment of chronic hepatitis C infection, a blood-borne infectious disease
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Sovaldi
Mylan signs exclusive agreement with Gilead Sciences
Under the agreement Mylan will distribute Sovaldi and Harvoni in India